Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287620 · ClinicalTrials.gov registry record
Objective, Passive Assessment of LRRK2 Carriers
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 10
- Enrollment target
NCT05287620 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 10 participants.
The verdict
NCT05287620 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The goal of this project is to identify objective, sensitive, and convenient measures for assessing early signs of Parkinson's disease in an at-risk population at home. We will do so by using a wireless sensor and analyzing the radio signals that bounce off patients' bodies, while patients go about their normal life without needing to wear sensors, answer questionnaires, or actively perform any tests.
Interventions
- DEVICE Emerald device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-04-27 |
| Est. Completion | 2024-05-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05287620
The ClinicalTrials.gov registry entry for NCT05287620 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Emerald device is the first listed.
NCT05287620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05287620 about?
NCT05287620 is a clinical study titled "Objective, Passive Assessment of LRRK2 Carriers". The goal of this project is to identify objective, sensitive, and convenient measures for assessing early signs of Parkinson's disease in an at-risk population at home. We will do so by using a wireless sensor and analyzing the radio signals that bounce off patients' bodies, while patients go about ...
What is the current status of trial NCT05287620?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2022-04-27. Estimated completion is 2024-05-07.
What interventions are being tested in trial NCT05287620?
The interventions under investigation include: Emerald device (DEVICE).
Who is sponsoring clinical trial NCT05287620?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.